BIOTECHNOLOGY INNOVATION ORGANIZATIONPub 78
Pub 78
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$117,748,708
Program Services
78%
Other
18%
Investments
4%
Contributions
0%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2024
$100,010,786
Salaries & Benefits
42%
Other
33%
Fees to Service Providers
13%
Offices, Occupancy & IT
8%
Grants
2%
Advertising & Promotion
1%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$0
$0
-
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$93,460,509
$91,769,762
-2%
Membership Dues
$0
$0
-
Investments
$2,063,448
$4,550,666
+121%
Other
$18,244,552
$21,428,280
+17%
Total Revenues
$113,768,509
$117,748,708
+3%
Expenses
2023
2024
Change
Grants
$1,534,902
$2,331,287
+52%
Benefits to Members
$0
$0
-
Salaries & Benefits
$37,224,329
$41,732,352
+12%
Fees to Service Providers
$11,076,541
$13,310,293
+20%
Advertising & Promotion
$894,217
$1,004,014
+12%
Offices, Occupancy & IT
$7,166,102
$8,016,012
+12%
Interest
$0
$0
-
Depreciation
$889,454
$914,712
+3%
Other
$32,844,619
$32,702,116
0%
Total Expenses
$91,630,164
$100,010,786
+9%
Net income
2023
2024
Change
Net income
+$22,138,345
+$17,737,922
-20%
Functional Expenses
Summary
2023
2024
Change
Program
-
-
-
Admin
-
-
-
Fundraising
-
-
-
Total Expenses
$91,630,164
$100,010,786
+9%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)